CDC: “COVID Data Tracker.”
The White House: “Press Briefing by Press Secretary Karine Jean-Pierre and COVID-19 Response Coordinator Dr. Ashish Jha.”
Center for infectious Disease Research and Policy: “CDC: 58% of Americans have had COVID-19.”
Stephen Kissler, PhD, infectious disease researcher, Harvard T.H. Chan School of Public Health, Boston.
Amesh Adalja, infectious disease specialist, Johns Hopkins Center for Health Security, Baltimore.
Neville Sanjana, PhD, geneticist, New York University and the New York Genome Center.
Benjamin tenOever, PhD, virologist, New York University.
Alessandro Sette, PhD, infectious disease expert, vaccine researcher, La Jolla Institute for Immunology, La Jolla, CA.
Ziyad Al-Aly, MD, infectious disease specialist, director of clinical epidemiology, Washington University in St. Louis.
Annals of Internal Medicine: “Prevalence of Asymptomatic SARS-CoV-2 Infection.”
JAMA Network: “Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis,” “Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021,” “Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis.”
Smithsonian Magazine: “What Scientists Are Learning About Covid-19 Using the Nation’s Blood Supply.”
CNN: “Rise in at-home testing means we could be undercounting Covid-19 cases even more than before.”
The New York Times: “Coronavirus in the U.S.: Latest Map and Case Count.”
NBC: “Scientists are narrowing in on why some people keep avoiding COVID-19.”
Cell: “Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells,” “Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed individuals.”
Genome Biology: “Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.”
Cancer Research: “Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.”
Nature Genetics: “Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.”
ResearchSquare: “Outcomes of SARS-CoV-2 Reinfection.”
Science: “Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans,” “Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.”
Cell Host & Microbe: “Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.”
The Journal of Allergy and Clinical Immunology: “Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study.”
Proceedings of the National Academy of Sciences. “Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.”
Annals of Internal Medicine: “Prevalence of Asymptomatic SARS-CoV-2 Infection.”
NPR: “Why hasn’t my daughter caught COVID? 2 factors likely protect her – and maybe you too.”
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg "Boosting CAR T cell survival to improve solid tumor therapy")
